ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,043Medicare Part D Prescriptions Filled, Including Refills

Rank: 144 out of 692

$765K Total Retail Price of All Prescriptions

Rank: 150 out of 692

640 Patients Receiving at Least One Drug in Part D
73% Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 640 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 640 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
OMEPRAZOLE 425 330 95 1 8
HYDROCODONE-ACETAMINOPHEN 381 296 110 S3 2 3
NAMENDA 330 312 25 3 29
FUROSEMIDE 326 286 72 4 7
QUETIAPINE FUMARATE 311 270 32 A 5 50
CYMBALTA 300 295* 31 6 41
LEVOTHYROXINE SODIUM 285 238 44 7 2
SIMVASTATIN 255 223 53 8 5
AMLODIPINE BESYLATE 252 213 57 9 1
TRAMADOL HCL 246 210 89 10 20
LISINOPRIL 238 204 57 11 4
ESCITALOPRAM OXALATE 224 191 44 12 33
METOPROLOL TARTRATE 216 155 54 13 16
ATORVASTATIN CALCIUM 212 207* 43 14 6
OLANZAPINE 209 164 27 A 15 105
CARVEDILOL 192 152 42 16 21
DONEPEZIL HCL 189 189 25 17 32
GABAPENTIN 188 156 45 18 12
WARFARIN SODIUM 174 145 30 19 28
NEXIUM 171 127 28 20 18
PRAVASTATIN SODIUM 164 143 31 21 10
CLOPIDOGREL 159 154* 28 22 17
ALPRAZOLAM 153 136 40 B 23 15
CITALOPRAM HBR 152 111 25 24 26
METOPROLOL SUCCINATE 143 118 33 25 13
RISPERIDONE 138 108 17 A 26 86
CLONIDINE HCL 137 108 39 27 37
PANTOPRAZOLE SODIUM 133 98 42 28 23
JANUVIA 123 64 13 29 59
ZOLPIDEM TARTRATE 122 106 36 30 25
METFORMIN HCL 115 63 33 31 9
MEGESTROL ACETATE 107 63 32 R 32 100
AZITHROMYCIN 106 69 72 33 51
LACTULOSE 105 73 35 34 96
NIFEDIPINE ER 104 86 20 35 75
LEVETIRACETAM 102 68 22 36 106
POTASSIUM CHLORIDE 102 97* 25 36 14
HYDRALAZINE HCL 97 73 18 38 68
DIGOX 97 80 21 38 88
NOVOLOG FLEXPEN 97 62 22 38 165
HYDROCHLOROTHIAZIDE 96 78 24 41 11
EXELON 96 84 14 41 112
TAMSULOSIN HCL 96 79 16 41 35
LEVEMIR FLEXPEN 96 62 14 41 143
SERTRALINE HCL 94 72 19 45 31
ALBUTEROL SULFATE 93 75 25 46 168
ADVAIR DISKUS 91 70 23 47 57
CLONAZEPAM 89 84* 29 B 48 46
MIRTAZAPINE 85 80* 17 49 76
IPRATROPIUM-ALBUTEROL 83 45 17 50 176
LEVOFLOXACIN 83 69 71 50 85
CRESTOR 82 <11 <11 52 27
VESICARE 81 <11 <11 53 108
POLYETHYLENE GLYCOL 3350 78 73* 30 54 69
LORAZEPAM 78 60 13 B 54 43
CARAFATE 77 <11 <11 56 282
DIVALPROEX SODIUM 77 63 12 56 102
SUCRALFATE 76 71* 23 58 150
OXYBUTYNIN CHLORIDE 74 74 17 59 129
DIOVAN 72 67* 16 60 34
LANTUS 71 66* 27 61 61
MELOXICAM 71 52 20 61 24
SANTYL 70 56 24 63 198
PAROXETINE HCL 64 52 14 64 84
AMIODARONE HCL 64 59* 15 64 166
BYSTOLIC 63 37 11 66 81
MONTELUKAST SODIUM 63 49 13 66 49
CIPROFLOXACIN HCL 62 35 48 68 64
AGGRENOX 60 <11 <11 69 158
VALSARTAN-HYDROCHLOROTHIAZIDE 59 48 12 70 63
FLUOXETINE HCL 58 <11 <11 71 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 41 18 71 38
TEMAZEPAM 55 44 11 B 73 67
RANITIDINE HCL 55 <11 <11 73 65
ZIPRASIDONE HCL 54 <11 <11 A 75 197
TRAZODONE HCL 54 49* 16 75 44
ALLOPURINOL 54 42 15 75 36
ISOSORBIDE MONONITRATE ER 53 48* 13 78 66
DOXAZOSIN MESYLATE 51 46* 13 79 80
METHYLPREDNISOLONE 50 34 41 80 92
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 15, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.